TRACEY CUNNINGHAM: Open Payments
NPI 1275942245 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 15 payments from 11 companies in 2025. Trend: 2023 $191 · 2024 $187 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| Lilly USA, LLC | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| PFIZER INC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: VRAYLAR, REXULTI, SPRAVATO, PAXLOVID, BREZTRI, Dexcom G6 Transmitter, Ozempic, MOUNJARO.
Industry payments across MD — which companies pay providers there.
